# OnCo record paper-monaleesa-2-n-engl-j-med-2022-update (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-monaleesa-2-n-engl-j-med-2022-update/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-monaleesa-2-n-engl-j-med-2022-update" ;
  schema:name "Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer"@en ;
  schema:description "Later report from the MONALEESA-2 trial registered as NCT01958021, in New England Journal of Medicine (2022); its title describes an updated or longer-term analysis."@en ;
  schema:url <https://onco.cc/key-papers/paper-monaleesa-2-n-engl-j-med-2022-update/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/nejmoa2114663>, <https://pubmed.ncbi.nlm.nih.gov/35263519/>, <https://europepmc.org/article/MED/35263519>, <https://clinicaltrials.gov/study/NCT01958021> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1056/nejmoa2114663> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Hortobagyi GN, Stemmer SM, Burris HA, et al." ;
  onco:trials <https://onco.cc/trials/monaleesa-2/> ;
  onco:journals <https://onco.cc/journals/nejm/> .